气管·支气管支架的全球市场:规模，占有率，COVID-19影响分析(2023年～2029年):MedCore

全球气管·支气管支架的市场规模在2022年估算为2亿1,630万美金。该市场在预测期间内预计将以-2.2％的年复合成长率减少，并达到1亿8,570万美元。

本报告提供全球气管·支气管支架市场相关调查，提供市场概要，以及各市场区隔，各地区趋势，竞争情形等资讯。

目录

气管·支气管支架市场

• 简介
• 市场概要
• 市场分析与预测
  • 气管·支气管支架市场
  • 气管·支气管金属支架市场
  • 气管·支气管硅胶支架市场
• 促进因素与阻碍因素
  • 推动市场要素
  • 阻碍市场要素
• 竞争市场占有率分析

The global market for tracheobronchial stents was valued at $216.3 million in 2022, with an anticipated decrease over the forecast period at a CAGR of -2.2%, ultimately reaching $185.7 million. The market report covers both metal and silicone tracheobronchial stents.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2029, and Historical Data to 2019

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

GLOBAL TRACHEOBRONCHIAL STENT MARKET INSIGHTS

A significant factor driving the market growth is the preference for silicone stents over their metal counterparts. Unlike metal stents, which are permanently implanted in a patient's airways, silicone stents can be removed or replaced to mitigate potential complications for the patient.

GLOBAL TRACHEOBRONCHIAL STENT MARKET SHARE INSIGHTS

The Global tracheobronchial market was led by Getinge, Boston Scientific, and Merit Medical.

Getinge was the top player in the tracheobronchial stent industry, operating exclusively in the metal tracheobronchial stent category with its iCAST™ Balloon Expandable Covered Stent. However, it's worth mentioning that a significant portion of the product sales may be utilized off-label for peripheral vascular interventions such as iliac, for which the international variant of the stent, Advanta™ V12, has CE and regional clearance.

MARKET SEGMENTATION SUMMARY

Tracheobronchial Stent Market - MedCore - Includes:

• Metal and silicone tracheobronchial stents.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Table of Contents

Tracheobronchial Stent Market

• 17.1 Introduction
• 17.2 Market Overview
• 17.3 Market Analysis and Forecast
  • 17.3.1 Tracheobronchial Stent Market
  • 17.3.2 Metal Tracheobronchial Stent Market
  • 17.3.3 Silicone Tracheobronchial Stent Market
• 17.4 Drivers and Limiters
  • 17.4.1 Market Drivers
  • 17.4.2 Market Limiters
• 17.5 Competitive Market Share Analysis

LIST OF CHARTS

• Chart 17-1: Tracheobronchial Stent Market by Segment, U.S., 2019 - 2029
• Chart 17-2: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022

LIST OF FIGURES

• Figure 17-1: Tracheobronchial Stent Market by Segment, U.S., 2019 - 2029 (US$M)
• Figure 17-2: Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-3: Metal Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-4: Silicone Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-5: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022